Inc. reports record financial results for the third quarter of 2023 and raises annual guidance

  Annual guidance has been increased to $136 million – $137 million, implying annual growth of 28%-29% SANTA CLARA, California, November 6, 2023 (GLOBE NEWSWIRE) – SI-BONE, Inc. (Nasdaq:SIBN), a medical device company committed to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended September 30, 2023. Recent Financial…